ProPhase Labs, Inc.
PRPH
$0.11
-$0.02-16.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -37.64% | -17.09% | -39.26% | 125.32% | -83.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -37.64% | -17.09% | -39.26% | 125.32% | -83.07% |
| Cost of Revenue | -16.24% | -69.08% | -62.54% | 176.04% | -80.11% |
| Gross Profit | -157.21% | 573.55% | 976.67% | 95.99% | -90.76% |
| SG&A Expenses | -29.48% | -33.30% | -43.94% | 145.33% | -20.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.48% | -41.12% | -48.99% | 271.37% | -46.80% |
| Operating Income | 26.48% | 46.13% | 52.00% | -57.77% | -0.03% |
| Income Before Tax | 6.38% | 52.35% | 42.18% | -68.84% | -10.14% |
| Income Tax Expenses | 93.74% | 134.06% | -- | 599.52% | -52.55% |
| Earnings from Continuing Operations | -37.74% | 18.14% | 15.31% | -302.12% | 3.42% |
| Earnings from Discontinued Operations | -- | -- | 1,266.53% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.83% | 27.32% | 163.30% | -292.63% | -28.13% |
| EBIT | 26.48% | 46.13% | 52.00% | -57.77% | -0.03% |
| EBITDA | 24.83% | 55.29% | 63.81% | -68.74% | -5.87% |
| EPS Basic | 52.32% | 66.94% | 132.43% | -217.49% | -15.34% |
| Normalized Basic EPS | 55.64% | 84.83% | 73.13% | -24.63% | 0.85% |
| EPS Diluted | 52.32% | 66.31% | 132.43% | -217.49% | -15.07% |
| Normalized Diluted EPS | 55.64% | 84.83% | 73.13% | -24.63% | 0.85% |
| Average Basic Shares Outstanding | 117.73% | 119.93% | 95.25% | 18.92% | 11.09% |
| Average Diluted Shares Outstanding | 117.73% | 119.93% | 95.25% | 18.92% | 11.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |